Bicara Therapeutics Inc.(BCAX:US)
Market Cap$1.1B
Key Metrics
Price$16.78
Revenue (TTM)$0
Holders Revenue (TTM)-
Gross Profit (TTM)-
Earnings (TTM)-$185.36M
EBITDA (TTM)-$201.84M
Op. Margin (TTM)-
Dividend Yield-
Holders Yield-
Cash on hand$323.46M
Total Assets$553.6M
Net Assets$513.96M
Total Debt$1.44M
Key Metrics
Price$16.78
Revenue (TTM)$0
Holders Revenue (TTM)-
Gross Profit (TTM)-
Earnings (TTM)-$185.36M
EBITDA (TTM)-$201.84M
Op. Margin (TTM)-
Dividend Yield-
Holders Yield-
Cash on hand$323.46M
Total Assets$553.6M
Net Assets$513.96M
Total Debt$1.44M
Financials
| Name | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Dec 31, 2023 | Sep 30, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
Cost of Revenue | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit | - | - | - | - | - | - | - | - | - | - | - |
| $59.95M | $60.24M | $41.12M | $40.68M | $32.02M | $41.79M | $26.64M | $20.63M | $19.75M | $13.69M | $9.53M | |
| Research and Development | $45.77M | $47.5M | $32.99M | $32.98M | $24.8M | $34.33M | $19.88M | $15.86M | $15.84M | $10.56M | $6.94M |
| Selling, General, and Administrative | $14.18M | $12.74M | $8.13M | $7.7M | $7.22M | $7.46M | $6.75M | $4.76M | $3.91M | $3.13M | $2.59M |
| Other Operating Expenses | - | - | - | - | - | - | - | - | - | - | - |
Operating Income | -$59.95M | -$60.24M | -$41.12M | -$40.68M | -$32.02M | -$41.79M | -$26.64M | -$20.63M | -$19.75M | -$13.69M | -$9.53M |
| $4.58M | $4.08M | $3.79M | $4.39M | $4.68M | $5.01M | $5.87M | $3.15M | $2.7M | $1.25M | -$13.32M | |
| Non-Operating Interest Income | $4.58M | $4.08M | $3.79M | $4.39M | $4.68M | $5.01M | $5.87M | $3.15M | $2.7M | $1.3M | $13K |
| Non-Operating Interest Expense | - | - | - | - | - | - | - | - | - | - | - |
| Other Income/Expense | - | - | - | - | - | - | - | - | - | -$49K | -$13.33M |
Income Before Tax | -$55.38M | -$56.16M | -$37.33M | -$36.29M | -$27.34M | -$36.77M | -$20.77M | -$17.48M | -$17.05M | -$12.44M | -$22.85M |
Income Tax | $61K | $52K | $53K | $40K | $52K | $72K | $186K | $0 | $0 | $5K | $0 |
Net Income | -$55.44M | -$56.21M | -$37.39M | -$36.33M | -$27.39M | -$36.85M | -$20.96M | -$17.48M | -$17.05M | -$12.44M | -$22.85M |
Minority Interests | - | - | - | - | - | - | - | - | - | - | - |
Preferred Stock Dividends | - | - | - | - | - | - | - | - | - | - | - |
Net Income to Common | -$55.44M | -$56.21M | -$37.39M | -$36.33M | -$27.39M | -$36.85M | -$20.96M | -$17.48M | -$17.05M | -$12.44M | -$22.85M |
Shares Outstanding (Basic) | 67.93M | 60.72M | 55.14M | 54.56M | 54.54M | 54.46M | 54.42M | 10.9M | - | - | 33.98M |
Shares Outstanding (Diluted) | 67.93M | 60.72M | 55.14M | 54.56M | 54.54M | 54.46M | 54.42M | 10.9M | - | - | 33.98M |
EPS (Basic) | -$0.82 | -$0.93 | -$0.68 | -$0.67 | -$0.50 | -$0.68 | -$0.39 | -$1.60 | - | - | -$0.67 |
EPS (Diluted) | -$0.82 | -$0.93 | -$0.68 | -$0.67 | -$0.50 | -$0.68 | -$0.39 | -$1.60 | - | - | -$0.67 |
EBIT | -$59.95M | -$60.24M | -$41.12M | -$40.68M | -$32.02M | -$41.79M | -$26.64M | -$20.63M | -$19.75M | -$25.78M | -$9.53M |
EBITDA | -$59.91M | -$60.2M | -$41.08M | -$40.65M | -$32M | -$41.77M | -$26.62M | -$20.61M | -$19.74M | -$25.76M | -$9.53M |